CD8A and metabolic dysfunction-associated steatotic liver disease: A recent study by Ghazarian et al. (2017) showed that type I IFN–driven activation of CD8+ T cells in the liver correlates with insulin resistance in obesity-linked fat liver (termed nonalcoholic fatty liver disease, NAFLD) in obese patients [107].